Postprandial Hyperglycemia: Treating Its Atherogenic Potential [hiperglicemia Pós-prandial: Tratamento Do Seu Potencial Aterogênico]

[No abstract available]875604613+660-670De Fronzo, R.A., Lilly lecture 1987. The triumvirate: Beta cell, muscle, liver. A collusion responsible for IDDM (1988) Diabetes, 37, pp. 667-687Stratton, I.M., Adler, A.I., Neil, H.A., Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): Prospective observational study (2000) BMJ, 321, pp. 405-412Standards of care for patients with diabetes mellitus (Position Statement) (2004) Diabetes Care, (SUPPL. 1), pp. S15-S35. , American Diabetes AssociationGlucose tolerance and cardiovascular mortality (2001) Arch Intern Med, 161, pp. 397-405. , DECODE Study GroupDinneen, S., Gerich, J., Rizza, R., Carbohydrate metabolism in non-insulin dependent diabetes mellitus (1992) N Engl J Med, 327, pp. 707-713Gavin III, J.R., Pathophysiologic mechanisms of postprandial hyperglycemia (2001) Am J Cardiol, 88 (SUPPL. 1), pp. 4H-8HLebovitz HE. A Symposium: Managing the atherogenic potential of the postprandial state. Am J Cardiol 200188(Suppl 1): 1H-3HMeyer, U., Gressner, A.M., Endocrine regulation of energy metabolism: Review of pathobiochemical and clinical chemical aspects of leptin, ghrelin, adiponectin, and resistin (2004) Clinical Chemistry, 50 (9), pp. 1511-1525Polonsky, K.S., Given, B.D., Hirsch, L.J., Abnormal patterns of insulin secretion in non-insulin-dependent diabetes mellitus (1988) N Engl J Med, 318, pp. 1231-1239Hall, L.D., Westland, R.E., Effects of size, time of day and sequence of meal ingestion on carbohydrate tolerance in normal subjects (1983) Diabetologia, 25, pp. 316-321. , Service FJYaney, G.C., Corkey, B.E., Fatty acid metabolism and insulin secretion in pancreatic beta cells (2003) Diabetologia, 46 (10), pp. 1297-1212Kahn, S.E., The importance of beta-cell in the pathogenesis of type 2 diabetes melitus (2000) Am J Med, 108, pp. 2S-8SPoitout, V., Robertson, R.P., Minireview: Secondary beta-cell failure in type 2 diabetes: a convergence of glucotoxicity and lipotoxicity (2002) Endocrinology, 143, pp. 339-342McKillop AM, Abdel-Wahab YH, Mooney MH, et al. Secretion of glycated insulin from pancreatic beta-cells in diabetes represents a novel aspect of beta-cell dysfunction and glucose toxicity. Diabetes Metab 200228: 3S61-69Visboll, T., Holst, J.J., Incretins, insulin secretion and Type 2 diabetes mellitus (2004) Diabetologia, 47 (3), pp. 357-366Bruce, D.G., Storlien, L.H., Furler, S.M., Chisholm, D.J., Cephalic phase metabolic responses in normal weight adults (1987) Metabolism, 36, pp. 721-725Mitrakou, A., Kelley, D., Mokan, M., Role of reduced suppression of glucose production and diminished early insulin release in impaired glucose tolerance (1992) N Engl J Med, 326, pp. 22-29Luzi, L., De Fronzo, R.A., Effect of loss of first-phase insulin secretion on hepatic glucose production and tissue glucose disposal in humans (1989) Am J Physiol, 257, pp. E241-E246Consoli, A., Nurjhan, N., Capani, F., Gerich, J., Predominant role of gluconeogenesis in increased hepatic glucose production in NIDDM (1989) Diabetes, 38, pp. 550-557Del Prato, S., Marchetti, P., Bonadonna, R.C., Phasic insulin release and metabolic regulation in type 2 diabetes (2002) Diabetes, 51 (SUPPL. 1), pp. S109-S116Weyer, C., Borgadus, C., Mott, D.M., Pratley, R.E., The natural history of insulin secretory dysfunction and insulin resistance in the pathogenesis of type 2 diabetes mellitus (1999) J Clin Invest, 104, pp. 787-794Freskens, E.J., Kromhout, D., Glucose tolerance and the risk of cardiovascular disease: The Zutphen Study (2001) J Clin Epidemiol, 54, pp. 869-876Haffner, S.M., Lehto, S., Ronnemma, T., Mortality from coronary artery disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction (1998) N Engl J Med, 339, pp. 229-234Avezum, A., Piegas, L.S., Pereira, J.C.R., Risk factors associated with acute miocardial infarction in the São Paulo metropolitan region. A developed region in a developing country (2005) Arq Bras Cardiol, 84 (3), pp. 206-213Moraes, S.A., de Souza, J.M., Diabetes Mellitus and ischemic heart disease. Comparison by gender (1996) Arq Bras Cardiol, 66 (2), pp. 59-63Matsubara, B.B., Okoshi, K., Okoshi, M.P., Arterial dysfunction as a possible mechanism of cardiac injury in type. A Doppler-echocardiographic study (1997) Arq Bras Cardiol, 69 (3), pp. 155-159Kannel, W.B., McGee, D.L., Diabetes and cardivascular disease. The Framingham study (1979) JAMA, 241, pp. 2035-2038Stamler, J., Vaccaro, O., Neaton, J.D., Wentworth, D., Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Interventional Trial (1993) Diabetes Care, 16, pp. 434-444Lee, W.L., Cheung, A.M., Cape, D., Zinman, B., Impact of diabetes on coronary artery disease in women and men: A meta-analysis of prospective studies (2000) Diabetes Care, 23, pp. 962-968Intensive blood-glucose control with sulphonylurea or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33) (1998) Lancet, 352, pp. 837-853. , UK Prospective Diabetes Study GroupLaakso, M., Hyperglycemia and cardiovascular disease in type 2 diabetes (1999) Diabetes, 48, pp. 937-942De Vegt, F., Dekker, J.M., Ruhè, H.G., Hyperglycaemia is associated with all-cause and cardiovascular mortality in the Hoorn population: The Hoorn Study (1999) Diabetologia, 42, pp. 926-931Donahue, R.P., Abbott, R.D., Reed, D.M., Yano, K., Postchallenge glucose concentration and coronary heart disease in men of Japanese ancestry: Honolulu Heart Program (1987) Diabetes, 36, pp. 689-692Glucose tolerance and mortality: Comparison of WHO and American Diabetes Association diagnostic criteria (1999) Lancet, 354, pp. 617-621. , The DECODE Study Group, the European Diabetes Epidemiology GroupCoutinho, M., Gerstein, H.C., Wang, Y., Yusuf, S., The relationship between glucose and incident cardiovascular events: A metaregression analysis of published data from 20 studies of 95,783 individuals followed for 12.4 years (1999) Diabetes Care, 22, pp. 233-240Fuller, J.H., Shipley, M.J., Rose, G., Coronary heart disease risk and impaired glucose tolerance: The Whitehall Study (1980) Lancet, 8183, pp. 1373-1376Fontbonne, A., Eschwege, E., Cambien, F., Hypertriglyceridaemia as a risk factor of coronary heart disease mortality in subjects with impaired glucose tolerance or diabetes. Results from the 11-year follow-up of the Paris Prospective Study (1989) Diabetologia, 32 (5), pp. 300-304Pyorala, K., Relationship of glucose tolerance and plasma insulin to the incidence of coronary heart disease: Results from two population studies in Finland (1979) Diabetes Care, 2 (2), pp. 131-141Bahia, L., Gomes, M.B., da Cruz, P.D.M., Gonçalves, M.D.F., Coronary artery disease, microalbuminuria and lipid profile in patients with non-insulin dependent diabetes mellitus (1999) Arq Bras Cardiol, 73 (1), pp. 11-22Zilversmidt, D.B., Atherogenesis: A postprandial phenomenon (1979) Circulation, 60, pp. 473-485Groot, P.H.E., Van Stiphout, W.A.H.J., Krauss, X.H., Postprandial lipoprotein metabolism in normolipidemic men with and without coronary artery disease (1991) Arterioscler Thromb, 11, pp. 653-662Patsch, J.R., Miesenböck, G., Hopferwieser, T., Relation of triglyceride metabolism and coronary artery disease. Studies in the postprandial state (1992) Arterioscler Thromb, 12, pp. 1336-1345Mamo, J.C.L., Proctor, S.D., Smith, D., Retention of chylomicron remnants by arterial tissueimportance of an efficient clearance mechanism from plasma (1998) Atherosclerosis, 141 (SUPPL.), pp. S63-S69Miesenböck, G., Patsch, J.R., Postprandial hyperlipidemia: The search for the atherogenic lipoprotein (1992) Curr Opin Lipidol, 3, pp. 196-201Ginsberg, H.N., Lipoprotein physiology in nondiabetic and diabetic states: Relationship to atherogenesis (1991) Diabetes Care, 14, pp. 839-855Ginsberg, H.N., Lipoprotein physiology (1998) Endocrinol Metabol Clin North Am, 27, pp. 503-519Pastch, J., Influence of lipolysis on chylomicron clearance and HDL cholesterol levels (1998) Eur Heart J, 19 (SUPPL. H), pp. H2-H6Ginsberg, H.N., Illingworth, D.R., Postprandial dyslipidemia: An atherogenic disorder common on patients with diabetes mellitus.Am (2001) J Cardiol, 11 (SUPPL.), pp. 4H-8HDaughert, Y.A., Lange, L.G., Sobel, B.E., Schonfeld, G., Aortic accumulation and plasma clearance of beta-VLDL and HDL: Effects of diet-induced hypercholesterolemia in rabbits (1985) J lipid Res, 16, pp. 955-963Rapp, J.H., Lespine, A., Hamilton, R.L., Triglyceride-rich lipoproteins isolated by selected-affinity anti-apolipoprotein B immunosortion from human atherosclerotic plaque (1994) Artherioscler Thromb, 14, pp. 1767-1774Cohn, J.S., Oxidized fat in the diet, postprandial lipaemia and cardiovascular disease (2002) Current Opinion in Lipidology, 13 (1), pp. 19-24Frayn, K.N., Insulin resistance, impaired postprandial lipid metabolism and abdominal obesity. A deadly triad (2002) Med Princ Pract, 11 (SUPPL. 2), pp. 31-40Lebovitz, H.E., Effect of the postprandial state on nontraditional risk factors.Am (2001) J Cardiol, 88 (SUPPL.), pp. 20H-25HHaller, H., Postprandial glucose and vascular disease (1997) Diabetic Medicine, 14, pp. S50-S56Giuliano, D., Marfella, R., Coppola, L., Vascular effects of acute hyperglycemia in humans are reversed by L-arginine: Evidence for reduced availability of nitric oxide during hyperglycemia (1997) Circulation, 95, pp. 1783-1790Heine, R.J., Dekker, J.M., Beyond postprandial hyperglycaemia: Metabolic factors associated with cardiovascular disease (2002) Diabetologia, 45, pp. 461-475Lee, I.K., Kim, H.S., Bae, J.H., Endothelial dysfunction: Its relantionship with acute hyperglycemia and hyperlipidemia (2002) Int J Clin Pract, 129 (SUPPL.), pp. 59-64Marfella, R., Verrazzo, G., Acampora, R., Glutathione reverses systemic hemodynamic changes by acute hyperglycemia in healthy subjects (1995) Am J Physiol, 268, pp. E1167-E1173Beckman, J.A., Goldfine, A.B., Gordon, M.B., Creager, M.A., Ascorbate restores endothelium-dependent vasodilation impaired by acute hyperglycemia in humans (2001) Circulation, 103, pp. 1618-1623Ceriello, A., Quagliaro, L., Piconi, L., Effect of postprandial hypertrigliceridemia and hyperglycemia on circulating adhesion molecules and oxidative stress generation and the possible role of simvastatin treatment (2004) Diabetes, 53, pp. 701-710Ceriello, A., Giugliano, D., Quatraro, A., Blood glucose may condition factor VII levels in diabetic and normal subjects (1988) Diabetologia, 31, pp. 889-891Ceriello, A., Giacomello, R., Stel, G., Hyperglycemia-induced thrombin formation in diabetes: The possible role of the oxidative stress (1995) Diabetes, 44, pp. 924-928Sakamoto, T., Ogawa, H., Kawano, H., Rapid change of platelet aggregability in acute hyperglycemia: Detection by a novel laser-light scattering method (2000) Thromb Haemost, 83, pp. 475-479Jones, R.L., Peterson, C.M., Reduced fibrinogen survival in diabetes mellitus a reversible phenomenon (1979) J Clin Invest, 63, pp. 485-493Ceriello, A., Falleti, E., Motz, E., Hyperglycemia-induced circulating ICAM-1 increase in diabetes mellitus: The possible role of oxidative stress (1998) Horm Metab Res, 30, pp. 146-149Marfella, R., Esposito, K., Giunta, R., Circulating adhesion molecules in humans: Role of hyperglycemia and hyperinsulinemia (2000) Circulation, 101, pp. 2247-2251Van Osostrom, A.J.H.H.M., Sijmonsma, T.P., Verseyden, C., Postprandial recruitment of neutrophils may contribuye to endotelial dysfunction (2003) J Lipid Res, 44, pp. 576-583Woerle, H.J., Pimenta, W.P., Meyer, C., Diagnostic and therapeutic implications of relationships between fasting, 2-hour postchallenge plasma glucose and hemoglobin A1c values (2004) Arch Intern Med, 164, pp. 1627-1632The American Association of Clinical Endocrinologists Medical Guidelines for the Management of Diabetes Mellitus: The AACE System of Intensive Diabetes Self-Management. Endocr Pract 20028 Suppl 1, 40-82Consenso Brasileiro sobre Diabetes 2002. Diagnóstico e classificação do diabetes melito e tratamento do diabetes melito do tipo 2. Rio de Janeiro: Diagraphic Editora2003De Venciana Major, C.A., Morgan, M.A., Tamerou, A., Toohey, J.S., Lien, J.M., EVANS, A.T., Postprandial versus preprandial blood glucose monitoring in women with gestacional diabetes mellitus requiring insulin therapy (1995) N Engl J Med, 333, pp. 1237-1241Bastyr, E.J., Stuart, C.A., Brodows, R.G., Therapy Focused on Lowering Postprandial Glucose, Not Fasting Glucose, May be Superior for Lowering HbA1c (2000) Diabetes Care, 23, pp. 1236-1241Monnier, L., Lapinski, H., Colette, C., Contributions of fasting and postprandial plasma glucose increments to overall diurnal hyperglycemia of type 2 diabetic patients (2003) Diabetes Care, 26, pp. 881-885Larsen, J.J., Dela, F., Kjaer, M., Galvo, H., The effect of intense exercise on postprandial glucose homeostasis in type 2 diabetic patients (1999) Diabetologia, 42, pp. 1282-1292Poirier, P., Mawhinney, S., Grondin, L., Prior meals enhances the plasma glucose lowering effect exercise in type 2 diabetes (2001) Med Sci Sports Exerc, 33, pp. 1259-1264Gill, J.M.R., Hardman, A.E., Postprandial lipemia: Effects of exercise and restriction of energy intake compared (2000) Am J Clin Nutr, 71, pp. 465-471Wolever, T.M., Bolgnesi, C., Source and amount of carbohydrate affect postprandial glucose and insulin in normal subjects (1996) J Nutr, 126, pp. 2798-2806Brenelli, S.L., Campos, S.D.S., Saad, M.J.A., Viscosity of gums in vitro and their ability to reduce postprandial hyperglycemia in normal subjects (1997) Brazilian J Med and Biol Res, 30, pp. 1437-1440Sheard, N.F., Clark, N.G., Brand-Miller, J.C., Dietary carbohydrate (amount and type) in the prevention and management of diabetes. A Statement by the American Diabetes Association (2004) Diabetes Care, 27 (9), pp. 2266-2271Hu, F.B., Willet, W.C., Optimal diets for prevention of coronary heart disease (2002) JAMA, 288, pp. 2569-2578Freiberg, M.S., Cabral, H.J., Heeren, T.C., Alcohol Consumption and the prevalence of the Metabolic Syndrome in the U.S (2004) Diabetes Care, 27, pp. 2954-2959Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin (2002) N Engl J Med, 346, pp. 393-403. , Diabetes Prevention Program Research GroupClark, H.E., Mattews, D.R., The effect of glimepiride on pancreatic beta-cell function under hyperglycaemic clamp and hyperinsulinaemic, euglycaemic clamp conditions in non-insulin-dependent diabetes mellitus (1996) Horm Metab Res, 28, pp. 445-450Ashcroft, F.M., Mechanisms of the glycaemic effercts of sulfonylureas (1996) Horm Metab Res, 28, pp. 456-463Shapiro, E.T., Van Cauter, E., Tillil, H., Glyburide enhances the responsiveness of the beta cell to glucose but does not correct the abnormal patterns of insulin secretion in non-insulin-dependent diabetes mellitus (1989) J Clin Endocrinol Metab, 69, pp. 571-576Dabrowski, M., Wahl, P., Holmes, W.E., Ashcroft, F.M., Effect of repaglinide on cloned beta cell, cardiac and smooth muscle types of ATP-sensitive potassium channels (2001) Diabetologia, 44, pp. 747-756Dornhorst, A., Insulinotropic meglitinide analogues (2001) Lancet, 358, pp. 1709-1716Nattrass, M., Lauritzen, T., Review of prandial glucose regulation with repaglinide: A solution to the problem of hypoglycaemia in the treatment of Type 2 diabetes? (2000) International Journal of Obesity, 24 (SUPPL. 3), pp. S21-S31Tankova, T., Dragomir, K., Dakovska, L., KiriloVG, The effect of repaglinide on insulin secretion and oxidative stress in type 2 diabetic patients (2003) Diab Res Clin Pract, 59, pp. 43-49Hanefeld, M., Bouter, K.P., Dickinson, S., Guitard, C., Rapid and short-acting mealtime insulin secretion with nateglinide controls both prandial and mean glycemia (2000) Diabetes Care, 23, pp. 202-207Inzucchi, S.E., Oral Antihyperglycemic Therapy for Type 2 Diabetes. Scientific Review (2002) JAMA, 287, pp. 360-372Bailey, C., Biguanides and NIDD (1992) Diabetes Care, 15 (2), pp. 755-772Bailey, C.J., Turner, R.C., Metformin (1996) N Engl J Med, 334, pp. 574-579Fery, F., Plat, L., Balasse, E.O., Effects of metformin on the pathways of glucose utilization after oral glucose in non-insulin-dependent diabetes mellitus patients (1997) Metabolism, 46 (2), pp. 227-233Effect of intensive glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34) (1998) Lancet, 352, pp. 854-865. , UK Prospective Diabetes Study GroupDay, C., Thiazolidinediones: A new class of antidiabetic drugs (1999) Diabetic Med, 16, pp. 1-14Rosen, E.D., Spiegelman, B.M., PPAR-γ: A nuclear regulator of metabolism, differentiation, and cell growth (2001) J Biol Chem, 276, pp. 37731-37734Raskin, P., Rappaport, E.B., Cole, S.T., Rosiglitazone short-term monotherapy lowers fasting and post-prandial glucose in patients with Type II diabetes (2000) Diabetologia, 43, pp. 278-284Fonseca, V., Grunberger, G., Gupta, S., Addition of nateglinide to rosiglitazone monotherapy suppresses mealtime hyperglycemia and improves overall glycemic control (2003) Diabetes Care, 26 (6), pp. 1685-1690Lebovitz, H.E., Alfa-Glucosidase inhibitors as agents in the treatment of diabetes (1998) Diabetes Revs, 6, pp. 132-145Holman RR, Cull CA, Turner RC on Behalf of The UKPDS Study GROUP. A randomized double-blind trial of acarbose in type 2 diabetes shows improved glycemic control over 3 years (U.K. Prospective Diabetes Study 44). Diabetes Care 199922(6): 960-4Hirsh, I.B., Insulin Analogues (2005) N Engl J Med, 352, pp. 174-183Evans, M., Anderson, R.A., Smith, J.C., Khan, N., Effects of insulin lispro and chronic vitamin C therapy on postprandial lipaemia, oxidative stress and endothelial function in patients with type 2 diabetes mellitus (2003) Europ J Clin Invest, 33, pp. 231-238Ceriello, A., Cavarape, A., Martinelli, L., The post-prandial state in Type 2 diabetes and endothelial dysfunction: Effects of insulin aspart (2004) Diabet Med, 21, pp. 171-175Hermansen, K., Colombo, M., Storgaard, H., Improved postprandial glycemic control with biphasic insulin aspart relative to biphasic human insulin in patients with type 2 diabetes (2002) Diabetes Care, 25 (5), pp. 883-888Raskin, P., Allen, E., Hollander, P., Initiating insulin therapy in type 2 diabetes: A comparison of biphasic and basal insulin analogs (2005) Diabetes Care, 28 (2), pp. 260-265Odegard, P.S., Capoccia, K.L., Inhaled Insulin: Exubera (2005) Ann Pharmacother, 39, pp. 843-853Turner, R.C., Cull, C.A., Frighi, V., Glycemic control with diet, sulfonylurea, metformin, or insulin in patients with type 2 diabetes mellitus: Progressive requirements for multiple therapies (1999) JAMA, 281, pp. 2005-2012Vuskan, V., Sievenpiper, J.L., Koo, V.Y.Y., American ginseng (Panax quinquefolius L) reduces postprandial glycemia in nondiabetic subjects and subjects with type 2 diabetes mellitus (2000) Arch Intern Med, 160, pp. 1009-1013Levetan, C., Want, L.L., Weyer, C., Impact of pramlintide on glucose fluctuations and postprandial glucose, glucagons, and triglyceride excursions among patients with type 1 diabetes intensively treated with insulin pumps (2003) Diabetes Care, 26, pp. 1-8Weyer, C., Gottleb, A., Kim, D.D., Pramlintide reduces postprandial glucose excursions when added to regular insulin or insulin lispro in subjects with type 1 diabetes (2003) Diabetes Care, 26, pp. 3074-3079Edwards, C.M., Stanley, S.A., DaVis, R., Exendin-4 reduces fasting and postprandial glucose and decreases energy intake in healthy volunteers (2001) Am J Physiol Endocrinol Metab, 281, pp. E155-E161Juhl, C.B., Hollingdal, M., Sturis, J., Bedtime administration of NN2211, a long-acting GLP-1 derivative, substantially reduces fasting and postprandial glycemia in type 2 diabetes (2002) Diabetes, 51, pp. 424-429Kolterman, O.G., Buse, J.B., Fineman, M.S., Synthetic Exendin-4 (Exenatide) significantly reduces postprandial and fasting plasma glucose in subjects with type 2 diabetes (2003) J Clin Endocrinol Metab, 88, pp. 3082-3089Ahrén, B.O., Simonsson, E., Larsson, H., Inhibition of dipeptidyl peptidase IV improves metabolic control over a 4-week study period in type 2 diabetes (2002) Diabetes Care, 25, pp. 869-87